
3D printing technology has driven major medical, dental, engineering, and education innovations. In oral and maxillofacial surgery (OMFS), 3D printing technology has been implemented to improve precision in treatment planning, increase surgical predictability, reduce operation times, and lower overall costs. Furthermore, 3D printing has opened access to surgical training, facilitated patient-physician relationships, and generated greater surgical outcomes. The aim of this review is to summarize the impact of 3D printing technology in the field of OMFS. We discuss its many applications in the management of maxillofacial trauma and reconstruction, orthognathic surgery, maxillofacial prosthodontics, temporomandibular joint (TMJ) reconstruction, dental implants (3D-printed surgical guides and 3D-printed dental implants), bone tissue engineering for maxillofacial regeneration, clinical education, and patient communication.
3D bioprinting is a powerful enabling technology for the automated fabrication of biomimetic constructs for skin modelling and repair with high resolution and reproducibility. Bioinks, which often comprise the combination of cells and printable biomaterials, are essential for bioprinting 3D cell-laden constructs emulating the architecture, composition and function of native skin. Tissue- and organ-specific decellularized extracellular matrix (dECM) materials are assuming a significant role in bioink design owing their capacity to provide native biophysical and biochemical signals that can elicit distinct cellular responses toward tissue development. Herein, we discuss the rational design of dECM-based bioinks, focusing on processing methods to obtain dECM as well as on bioprinting strategies to engineer 3D constructs for applications in wound healing and in vitro skin modelling.
With the increasing complexity and difficulty of surgical procedures, there is an urgent need for empirical and high-fidelity surgical teaching tools. Whereas in the past, teaching tools included cadavers and animals, today, with the development of three-dimensional (3D) printing technology, the creation of patient-specific organ models is possible. This technology provides an effective solution for preoperative rehearsal, thus providing surgery residents with a more realistic simulation environment. This study aimed to provide an overview of the use of personalized 3D printing in various types of surgery through a scoping review, outline their bottlenecks, and provide an outlook. Significant advancements have been made in 3D-printed gel organ models for surgical applications. However, future advancements require interdisciplinary collaborations, medical–engineering integration and novel techniques. Addressing challenges in preservation, instrument response, ultrasound performance and mechanical properties is crucial. Enhancing these aspects will improve the capabilities of organ models, benefiting both medical practitioners and patients.
Aim: A limited number of studies have attempted to quantify the advantages of using in-house 3D printed models. We designed a pilot study to assess the value of in-house production of patient-specific 3D-printed models in pre-surgical planning. Methods: A 12-question survey was designed and sent to surgeons to assess any purported benefits of 3D-printed anatomic models. In-house 3D model printing was completed on a Stratasys J750 Polyjet printer. Each 3D printed model was delivered to the supervising surgeon days before the procedure for final validation. The 3D models were subsequently utilized in the operating room. Results: A total of 50 surveys were completed for a response rate of 100%. Approximately 94% of the participants strongly agreed that the 3D-printed model was a valuable clinical tool for pre-surgical planning. The majority of the respondents (78%) reported improved surgical efficiency. Conclusion: 3D models is a valuable tool for surgical planning.
3D-printed (3DP) polycaprolactone (PCL)-based scaffolds have gained popularity in the past decade. Despite the wide utility of autografts for bone regeneration in orthopedics practice, 3DP PCL scaffolds may replace this general application. Here we present a 42-year-old patient who had glenohumeral arthritis due to rheumatoid arthritis accompanied by a Walch 3 glenoid defect, and a 19-year-old patient with neglected Galeazzi fracture–dislocation accompanied by a radius non-union. In both patients, a 3DP PCL + hyaluronic acid-based scaffold was used for bone regeneration purposes. The preliminary results showed that the 3DP PCL + hyaluronic acid scaffold provided bone regeneration and may be a promising alternative to autografting for bone regeneration in orthopedic practice.